UPF1 and amyotrophic lateral sclerosis: The neuroprotection observed by UPF1 appeared to be through modulation of the NMD pathway for FUS-ALS and TDP43-ALS, as pharmacological inhibition of NMD increased the observed neurotoxicity (Barmada et al., 2015).